Literature DB >> 16215059

Refeeding syndrome in hospitalized pediatric patients.

Rebecca L Dunn1, Nicolas Stettler, Maria R Mascarenhas.   

Abstract

Refeeding syndrome has been well documented over the years, primarily through case reports and literature reviews. Awareness of refeeding syndrome is crucial in preventing the occurrence of, and the metabolic and physiologic complications associated with, aggressive nutrition support in malnourished populations. Once compromised patients have been identified to be at risk of refeeding syndrome, nutrition rehabilitation should be cautiously initiated. We have found a lack of clinical validation for instituting nutrition support in high-risk pediatric patients who may develop refeeding syndrome. The purposes of our investigation were to determine the incidence of refeeding syndrome in pediatric hospitalized patients beginning on parenteral nutrition and to determine how consistently the Department of Clinical Nutrition standards of care for screening and prevention were followed at our institution.

Entities:  

Year:  2003        PMID: 16215059     DOI: 10.1177/0115426503018004327

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  3 in total

1.  Incidence of Refeeding Syndrome in Critically Ill Children With Nutritional Support.

Authors:  Stéphanie Blanc; Tajnja Vasileva; Lyvonne N Tume; Florent Baudin; Carole Chessel Ford; Corinne Chaparro Jotterand; Frederic V Valla
Journal:  Front Pediatr       Date:  2022-06-21       Impact factor: 3.569

2.  Outcomes of an inpatient refeeding protocol in youth with anorexia nervosa: Rady Children's Hospital San Diego/University of California, San Diego.

Authors:  Tamara R Maginot; Maya M Kumar; Jacqueline Shiels; Walter Kaye; Kyung E Rhee
Journal:  J Eat Disord       Date:  2017-01-03

3.  Risk Factors for the Development of Refeeding Syndrome-Like Hypophosphatemia in Very Low Birth Weight Infants.

Authors:  Aiko Igarashi; Takashi Okuno; Genrei Ohta; Shuko Tokuriki; Yusei Ohshima
Journal:  Dis Markers       Date:  2017-09-05       Impact factor: 3.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.